Tai Chi-muscle Power Training for Primary School Children With Developmental Coordination Disorder
Launched by THE UNIVERSITY OF HONG KONG · Jul 14, 2018
Trial Information
Current as of June 09, 2025
Unknown status
Keywords
ClinConnect Summary
Children with developmental coordination disorder (DCD), who comprise about 6% of the primary school population, display marked movement and balance difficulties. Reduced limits of stability (LOS), the maximum spatial area in which a standing person can lean, in these children is a major concern because it predisposes them to falls and affects their motor development.
The investigator's recent studies demonstrate the underlying causes of impaired LOS in children with DCD to include suboptimal volitional control of the center of gravity (COG) and reduced leg muscle force production speed. T...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 9- to 12-years-old
- • Classified as DCD according to the Diagnostic and Statistical Manual of Mental Disorders V (DSM-5)
- • A percentile score of \< 5th percentile on the MABC-2
- • A total score of \< 55 (for children aged 8 to 9 years 11 months) or \< 57 (for children aged 10 or above) on the DCD questionnaire 2007 (Chinese version)
- • Attending a mainstream primary school (i.e., intelligence level within the normal range)
- Exclusion Criteria:
- • Any known significant congenital, cognitive, psychiatric (other than comorbid attention deficit hyperactivity disorder \[ADHD\] or autism spectrum disorder \[ASD\]), neurological, sensory, musculoskeletal, or cardiopulmonary disorder that may affect motor performance
- • Receiving active treatment such as physiotherapy
- • Demonstrating excessive disruptive behavior during the assessments
- • Those unable to follow instructions properly
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Shirley Fong, PhD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials